Evidence map›Paper›PMID 30655513›Full record

ArticleNature communications2019

Interferon lambda protects the female reproductive tract against Zika virus infection.

Elizabeth A Caine, Suzanne M Scheaffer, Nitin Arora, Konstantin Zaitsev, Maxim N Artyomov, Carolyn B Coyne, Kelle H Moley, Michael S Diamond

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 2 pooled it
16.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 2 syntheses or guidelines pooled it, 110 citations in OpenAlex.

  1. Pooled it
  2. Zika virus infection in the genital tract of non-pregnant females: a systematic review.Revista do Instituto de Medicina Tropical de Sao Paulo · 2020
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Microbiota-dependent IFN-L controls uterine and placental immunity.bioRxiv : the preprint server for biology · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Meeting the Challenge of Controlling Viral Immunopathology.International journal of molecular sciences · 2024
    Review
  18. Article
  19. Review
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Elizabeth A CaineDepartments of Medicine, Washington University School of Medicine, Saint Louis, MO, 63110, USA.ORCID http://orcid.org/0000-0002-7548-7330
Suzanne M ScheafferObstetrics and Gynecology, Washington University School of Medicine, Saint Louis, MO, 63110, USA.
Nitin AroraDepartments of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15224, USA.
Konstantin ZaitsevDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO, 63110, USA.ORCID http://orcid.org/0000-0003-3749-0886
Maxim N ArtyomovDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO, 63110, USA.
Carolyn B CoyneDepartments of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15224, USA. coynec2@pitt.edu.ORCID http://orcid.org/0000-0002-1884-6309
Kelle H MoleyObstetrics and Gynecology, Washington University School of Medicine, Saint Louis, MO, 63110, USA. moleyk@wustl.edu.
Michael S DiamondDepartments of Medicine, Washington University School of Medicine, Saint Louis, MO, 63110, USA. diamond@wusm.wustl.edu.ORCID http://orcid.org/0000-0002-8791-3165
Washington University in St. Louis · USUniversity of Pittsburgh · USITMO University · RU

Funding

Antibody-based Protection against FlavivirsesR01AI073755 · NIAID · WASHINGTON UNIVERSITY · PI DIAMOND, MICHAEL S, FREMONT, DAVED H. · 2007 to 2022
$11.4M
Washington University Intellectual and Developmental Disabilities Research Center-Administrative Down Syndrome SupplementU54HD087011 · NICHD · WASHINGTON UNIVERSITY · PI MOLEY, KELLE H · 2015 to 2019
$7.1M
Microbial Pathogenesis &Host Responses Training ProgramT32AI055397 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI KLEIN, BRUCE STEVEN · 2003 to 2024
$5.5M
Enterovirus Infection of Polarized Intestinal CellsR01AI081759 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI COYNE, CAROLYN B · 2009 to 2024
$5.0M
Innate Immune Regulation of Zika Virus InfectionR01AI145296 · NIAID · UNIVERSITY OF WASHINGTON · PI COYNE, CAROLYN B, DIAMOND, MICHAEL S · 2019 to 2023
$4.1M
Safety, Testing/Transmission, and Outcomes in Pregnancy with COVID-19 (STOP-COVID-19 study)R01HD091218 · NICHD · WASHINGTON UNIVERSITY · PI DIAMOND, MICHAEL S, MYSOREKAR, INDIRA U · 2017 to 2022
$4.1M
Human neutralizing antibodies for Zika virusR01AI127828 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CROWE, JAMES E, DIAMOND, MICHAEL S · 2017 to 2021
$3.9M
Maternal nutrition and oocyte programmingR01HD083895 · NICHD · WASHINGTON UNIVERSITY · PI ENGLAND, SARAH K. · 2015 to 2019
$2.7M
Primary human trophoblasts and the transfer of viral resistanceR01HD075665 · NICHD · MAGEE-WOMEN'S RES INST AND FOUNDATION · PI COYNE, CAROLYN B, SADOVSKY, YOEL · 2012 to 2016
$2.4M
NIAID NIH HHS R01 AI073755NIAID NIH HHS R01 AI081759NIAID NIH HHS R01 AI127828NIAID NIH HHS R01 AI145296NIAID NIH HHS T32 AI055397NICHD NIH HHS R01 HD075665NICHD NIH HHS R01 HD083895NICHD NIH HHS R01 HD091218NICHD NIH HHS U54 HD087011
6 · The paper itself

Abstract

Although Zika virus (ZIKV) can be transmitted sexually and cause congenital birth defects, immune control mechanisms in the female reproductive tract (FRT) are not well characterized. Here we show that treatment of primary human vaginal and cervical epithelial cells with interferon (IFN)-α/β or IFN-λ induces host defense transcriptional signatures and inhibits ZIKV infection. We also assess the effects of IFNs on intravaginal infection of the FRT using ovariectomized mice treated with reproductive hormones. We find that mice receiving estradiol are protected against intravaginal ZIKV infection, independently of IFN-α/β or IFN-λ signaling. In contrast, mice lacking IFN-λ signaling sustain greater FRT infection when progesterone is administered. Exogenous IFN-λ treatment confers an antiviral effect when mice receive both estradiol and progesterone, but not progesterone alone. Our results identify a hormonal stage-dependent role for IFN-λ in controlling ZIKV infection in the FRT and suggest a path for minimizing sexual transmission of ZIKV in women.

Indexed as

Administration, IntravaginalAnimalsAntiviral AgentsCervix UteriDisease Models, AnimalEpithelial CellsEstradiolFemaleHost-Pathogen InteractionsHumansInterferon-alphaInterferon-betaInterferon LambdaInterleukinsMiceMice, Inbred C57BLAntiviral AgentsEstradiolInterferon-alphaInterferon-betaInterferon Lambdainterferon-lambda, humanInterleukinsProgesterone

Identifiers

PMID30655513
PMCPMC6336786
OpenAlexW2909107489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.